2024
-
Controversies session to examine questions in translational medicine
Antonio Wolff, MD, will moderate a Wednesday afternoon session on questions that will inform clinical trial design and guide treatment decisions.
-
SABCS® Co-Directors: Welcome to the 2024 Symposium
San Antonio Breast Cancer Symposium® Co-Directors Carlos Arteaga, MD, and Virginia Kaklamani, MD, share a message for the thousands of attendees joining the SABCS® in person and virtually this week.
-
SABCS® Daily Highlights for Tuesday, December 10
Plan your Tuesday schedule and don’t miss notable items on the program, including concurrent Special Sessions and Educational Sessions that address hot topics in breast cancer.
-
Special session to provide behind-the-scenes look at recent FDA approvals
Laleh Amiri-Kordestani, MD, and Eric Winer, MD, will moderate a Tuesday afternoon special session on new drug approvals, featuring insights from oncology experts at the U.S. Food and Drug Administration.
-
Risk Reduction and Early Detection: The Future of Cancer Genetics Is Here — Presenter Profile
Fergus Couch, PhD, discusses a presentation in a Thursday afternoon Risk Reduction and Early Detection session.
-
Clinical Workshop to review dosage, regimen optimization in breast medical oncology
Mirat Shah, MD, will serve as one of the moderators for a Tuesday afternoon session that will reinforce the need for dosage and regimen optimization in breast cancer drug development and clinical trial design.
-
Clinical Controversies: Omission of Axillary Staging in ER ER-Positive Cancer: Implications on Adjuvant Therapies — Presenter Profile
Kevin Kalinsky, MD, MS, discusses a presentation in a Thursday afternoon Clinical Controversies session.
-
Educational Session 9: Artificial Intelligence in the Clinic — Presenter Profiles
Andrew Hantel, MD, and Emily Ray, MD, MPH, discuss presentations in a Thursday afternoon educational session.
-
Educational Session 5: Unlocking New Targets with Molecular Degraders — Presenter Profile
Stephen M. Hinshaw, PhD, discusses a presentation in a Wednesday afternoon educational session.
-
State of the Art Session 1: The Winding Road of Immune Biomarkers in Early Breast Cancer — Presenter Profiles
Roberto Salgado, MD, PhD; Justin M. Balko, PharmD, PhD; and Priyanka Sharma, MD, discuss presentations in a Wednesday afternoon State of the Art session.